Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microglia.

bioRxiv : the preprint server for biology·2026
Same author

RUNX1 and YY1 modulate neuronal fate and energy metabolism in Alzheimer's disease.

bioRxiv : the preprint server for biology·2026
Same author

Pharmacological clearance of senescent cells reduces inflammation, endothelial damage and cardiac fibrosis in HFpEF.

Cardiovascular research·2025
Same author

Reprogramming Stars #25: Modeling Brain Aging with Direct Reprogramming of Skin Cells into Neurons-An Interview with Dr. Jerome Mertens.

Cellular reprogramming·2025
Same author

Galectin-3: a novel biomarker of glycogen storage disease type III.

Cell death discovery·2025
Same author

An accelerated human in-vitro aging model mimicsin-vivo aging and facilitates dynamic testing of anti-aging compounds.

Research square·2025

相关实验视频

Updated: Jul 2, 2025

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.6K

细胞重编程作为一种工具,以模拟人类的衰老.

Patricia R Pitrez1,2, Luis M Monteiro1,2,3, Oliver Borgogno4,5

  • 1Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

Nature communications
|February 28, 2024
PubMed
概括

使用干细胞的人类模型系统可以揭示衰老机制,并指导开发延长健康和寿命的干预措施. 这些模型为抗衰老研究提供了新的途径.

更多相关视频

Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

16.9K
Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research
08:20

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research

Published on: May 12, 2023

3.3K

相关实验视频

Last Updated: Jul 2, 2025

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle
09:14

Evaluation of Injury-induced Senescence and In Vivo Reprogramming in the Skeletal Muscle

Published on: October 26, 2017

9.6K
Induction and Validation of Cellular Senescence in Primary Human Cells
08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

16.9K
Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research
08:20

Robust Tissue Fabrication for Long-Term Culture of iPSC-Derived Brain Organoids for Aging Research

Published on: May 12, 2023

3.3K

科学领域:

  • 老年学和再生医学.
  • 干细胞生物学和组织工程.

背景情况:

  • 了解人类衰老对于开发延长健康寿命的干预措施至关重要.
  • 现有的模型在总结人类衰老过程方面存在局限性.

研究的目的:

  • 探索2D和3D人类细胞培养模型研究衰老的潜力.
  • 利用来自老年捐献者的诱导多能干细胞和转基因细胞.

主要方法:

  • 开发2D和3D培养系统,使用人类诱导的多能干细胞.
  • 使用来自老年或患有年龄相关疾病的捐赠者的细胞.
  • 研究这些人类模型系统中衰老的潜在机制.

主要成果:

  • 来自老年捐赠者的人类细胞模型在重复老龄化表型方面显示出希望.
  • 这些模型有助于研究与年龄相关的分子和细胞变化.
  • 这些模型为选潜在的抗衰老化合物提供了一个平台.

结论:

  • 2D和3D人类细胞培养模型是衰老研究的宝贵工具.
  • 这些系统提高了对人类衰老机制的理解.
  • 它们加速了对促进健康衰老和延长寿命的干预措施的发现.